VXRT Return on Tangible Equity | Vaxart, Inc.

Vaxart, Inc. (VXRT) Return on Tangible Equity

2026-06-30: Return Tang Equity 51.18%.
2026-03-31: Return Tang Equity 42.66%.
2025-12-31: Return Tang Equity 20.29%.
2025-09-30: Return Tang Equity -263.54%.

Complete source-backed return tang equity history.

Available history: 2009-12-26 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	51.18%
2026-03-31	42.66%
2025-12-31	20.29%
2025-09-30	-263.54%
2025-06-30	-224.97%
2025-03-31	-154.03%
2024-12-31	-131.63%
2024-09-30	-120.17%
2024-06-30	-105.69%
2024-03-31	-173.64%
2023-12-31	-168.27%
2023-09-30	-142.32%
2023-06-30	-132.94%
2023-03-31	-134.06%
2022-12-31	-106.62%
2022-09-30	-96.69%
2022-06-30	-72.20%
2022-03-31	-52.49%
2021-12-31	-40.88%
2021-09-30	-33.30%
2021-06-30	-29.18%
2021-03-31	-29.09%
2020-12-31	-29.82%
2020-09-30	-21.37%
2020-06-30	-91.40%
2020-03-31	-127.13%
2019-12-31	450.25%
2019-09-30	-1244.59%
2019-06-30	871.62%
2019-03-31	357.54%
2018-12-31	219.54%
2018-09-30	320.67%
2018-06-30	-866.93%
2018-03-31	-49.26%
2017-12-31	15.77%
2017-09-30	-128.52%
2017-06-30	-137.48%
2017-03-31	-120.40%
2016-12-31	104.89%
2016-09-30	-78.85%
2016-06-30	-55.00%
2016-03-31	-72.76%
2015-12-31	-55.50%
2015-09-30	-29.70%
2015-06-30	-27.56%
2015-03-31	-11.56%
2014-12-31	-9.00%
2014-09-30	-18.02%
2014-06-30	-12.69%
2014-03-31	-7.62%
2013-12-31	-16.12%
2013-09-30	-8.70%
2013-06-30	-13.20%
2013-03-31	-10.48%
2012-12-31	-13.58%
2012-09-30	-78.83%
2012-06-30	-25.96%
2012-03-31	-22.91%
2011-12-31	-14.24%
2011-09-24	-14.62%
2011-06-25	-6.39%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	20.29%
2024-12-31	-131.63%
2023-12-31	-168.27%
2022-12-31	-106.62%
2021-12-31	-40.88%
2020-12-31	-29.82%
2019-12-31	450.25%
2018-12-31	219.54%
2017-12-31	24.37%
2017-06-30	-162.43%
2016-06-30	-55.70%
2015-06-30	-27.72%
2014-06-30	-12.75%
2013-06-30	-13.20%
2012-06-30	-33.39%
2011-12-31	-7.70%
2011-06-30	-31.20%
2010-12-25	1.45%
2009-12-26	-19.23%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kalaris Therapeutics, Inc. (KLRS)	United States	$0.073B	-2.19
Atara Biotherapeutics, Inc. (ATRA)	United States	$0.086B	-6.48
Pelthos Therapeutics Inc. (PTHS)	United States	$0.086B	-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)	United States	$0.070B	-68.02
COGNITION THERAPEUTICS INC (CGTX)	United States	$0.090B	-6.52
BioStem Technologies, Inc. (BSEM)	United States	$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)	United States	$0.065B
MiNK Therapeutics, Inc. (INKT)	United States	$0.063B	-5.37
Cardiff Oncology, Inc. (CRDF)	United States	$0.101B	-2.22
EXOZYMES INC. (EXOZ)	United States	$0.058B